Type:Notice
Citation:86 FR 8220
Reading Time:about a minute or two
Mylan Pharmaceuticals Inc. has submitted an application to be recognized as an importer of controlled substances. The Drug Enforcement Administration (DEA), a part of the Justice Department, is providing notice of this application. Interested parties, such as other registered manufacturers or applicants, have the opportunity to submit written comments, objections, or requests for a hearing on this application by March 8, 2021. Comments and hearing requests should be sent to the DEA at their Springfield, Virginia address.
Simple Explanation
Mylan Pharmaceuticals wants permission to bring certain special medicines into the country, and the government wants to hear what people think about this by March 8, 2021.